Literature DB >> 19448123

Pediatric soft-tissue tumors and pseudo-tumors: MR imaging features with pathologic correlation: part 1. Imaging approach, pseudotumors, vascular lesions, and adipocytic tumors.

Oscar M Navarro1, Eoghan E Laffan, Bo-Yee Ngan.   

Abstract

A wide spectrum of entities may give rise to soft-tissue masses in children, including benign and malignant tumors, pseudotumors, and both neoplastic and nonneoplastic vascular lesions. Because of its excellent tissue contrast, multiplanar capability, and lack of ionizing radiation, magnetic resonance (MR) imaging has become the modality of choice in the evaluation of deep and large soft-tissue masses in children. In the vast majority of cases, however, accurate interpretation of the MR imaging findings requires correlation with the clinical findings. For example, in most posttraumatic and inflammatory pseudotumors, the clinical history is fundamental to establishing the diagnosis. In the evaluation of periarticular cysts, the location of the mass and its relationship to a joint are crucial for diagnosis, whereas in the evaluation of vascular lesions, including hemangiomas and vascular malformations, clinical findings combined with MR imaging findings are needed for accurate diagnosis in most cases. The identification of fat within adipocytic tumors is useful, but tissue biopsy may be required for final diagnosis. Nevertheless, MR imaging is useful in determining the origin and character of pediatric soft-tissue masses, defining their extent and their relationship to adjacent structures, and performing posttherapy follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19448123     DOI: 10.1148/rg.293085168

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  38 in total

1.  Soft-tissue inflammatory myofibroblastic tumors (IMTs) of the limbs: potential and limits of diagnostic imaging.

Authors:  Carlo Masciocchi; Giuseppe Lanni; Laura Conti; Armando Conchiglia; Eva Fascetti; Stefano Flamini; Gino Coletti; Antonio Barile
Journal:  Skeletal Radiol       Date:  2011-09-24       Impact factor: 2.199

Review 2.  Imaging evaluation of fetal vascular anomalies.

Authors:  Maria A Calvo-Garcia; Beth M Kline-Fath; Denise M Adams; Anita Gupta; Bernadette L Koch; Foong-Yen Lim; Tal Laor
Journal:  Pediatr Radiol       Date:  2014-12-10

Review 3.  Ultrasound evaluation of superficial lumps and bumps of the extremities in children: a 5-year retrospective review.

Authors:  Samir H Shah; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2013-03-12

4.  Multidetector computed tomography evaluation of cavernous haemangioma of the azygous vein.

Authors:  Karuna Moy Das; Ali M Ahmed; Abdulwahab Aljubab; Mohammed A Alzoum
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-09

Review 5.  Soft tissue tumours: imaging strategy.

Authors:  Hervé J Brisse; Daniel Orbach; Jerzy Klijanienko
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 6.  Magnetic resonance imaging of pediatric soft-tissue vascular anomalies.

Authors:  Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2016-05-26

Review 7.  Up-to-date imaging review of paediatric soft tissue vascular masses, focusing on sonography.

Authors:  Paolo Tomà; Francesco Esposito; Claudio Granata; Guglielmo Paolantonio; Maria Chiara Terranova; Giuseppe Lo Re; Dolores Ferrara; Massimo Rollo; Massimo Zeccolini; Sergio Salerno
Journal:  Radiol Med       Date:  2019-06-11       Impact factor: 3.469

8.  Clinical and imaging features of Kaposiform Hemangioendothelioma.

Authors:  Pei-An Hu; Zheng-Rong Zhou
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

Review 9.  Pelvic vascular malformations.

Authors:  Brian M Christenson; Matthew G Gipson; Mitchell T Smith
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

10.  MR Angiographic-Guided Percutaneous Sclerotherapy for Venous Vascular Malformations: A Radiation Dose-Reduction Strategy.

Authors:  S G Imbesi; D A Green; A Cho; R S Pakbaz
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.